Literature DB >> 18945393

Determinants of HIV shedding in the lower genital tract of women.

Brenna L Anderson1, Susan Cu-Uvin.   

Abstract

Heterosexual spread of HIV remains the major risk factor for transmission worldwide. Genital secretions from the infected partner contain both cell-free and cell-associated virus. Although the exact mechanism of heterosexual transmission is unknown, genital virus plays an important role. Decreasing the genital shedding of HIV is an important step in slowing the spread of the disease. Recent studies have shown that antiretroviral penetration into the genital tract varies by class and that antiretroviral therapy significantly decreases HIV levels. Compartmentalization between the blood and genital tract is based on viral load levels, resistant variants, viral diversity, and coreceptor usage. HSV-2, lack of lactobacilli, and plasma cell endometritis increased HIV genital shedding. HSV-2 suppressive therapy significantly reduces plasma and genital tract viral load. Data are conflicting on the effect of hormonal contraception on HIV genital shedding. Further studies are needed to translate these findings into decreased spread on a population level.

Entities:  

Year:  2008        PMID: 18945393     DOI: 10.1007/s11908-008-0082-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

1.  Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.

Authors:  R M van Praag; R P van Heeswijk; S Jurriaans; J M Lange; R M Hoetelmans; J M Prins
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

2.  Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.

Authors:  Naumann I Chaudry; Joseph J Eron; Odin J Naderer; Arlene S Pereira; M B Wire; Susan A Fiscus; Angela D M Kashuba
Journal:  Clin Infect Dis       Date:  2002-08-23       Impact factor: 9.079

3.  Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women.

Authors:  Sherene S Min; Amanda H Corbett; Naser Rezk; Susan Cu-Uvin; Susan A Fiscus; Leslie Petch; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

4.  Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.

Authors:  Julie B Dumond; Rosa F Yeh; Kristine B Patterson; Amanda H Corbett; Byung Hwa Jung; Naser L Rezk; Arlene S Bridges; Paul W Stewart; Myron S Cohen; Angela D M Kashuba
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

5.  Lack of association between genital tract HIV-1 RNA shedding and hormonal contraceptive use in a cohort of Louisiana women.

Authors:  Rebecca A Clark; Katherine P Theall; Angela M Amedee; Jeanne Dumestre; Luann Wenthold; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

6.  Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.

Authors:  S Taylor; R P van Heeswijk; R M Hoetelmans; J Workman; S M Drake; D J White; D Pillay
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

7.  Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.

Authors:  J M Baeten; S B Mostad; M P Hughes; J Overbaugh; D D Bankson; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-01       Impact factor: 3.731

8.  Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

Authors:  Jade Ghosn; Marie-Laure Chaix; Gilles Peytavin; Elisabeth Rey; Jean-Louis Bresson; Cécile Goujard; Christine Katlama; Jean-Paul Viard; Jean-Marc Tréluyer; Christine Rouzioux
Journal:  AIDS       Date:  2004-09-24       Impact factor: 4.177

9.  A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.

Authors:  Elizabeth M Stringer; Christine Kaseba; Jens Levy; Moses Sinkala; Robert L Goldenberg; Benjamin H Chi; Inutu Matongo; Sten H Vermund; Mulindi Mwanahamuntu; Jeffrey S A Stringer
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

10.  Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

Authors:  Deborah Watson-Jones; Helen A Weiss; Mary Rusizoka; John Changalucha; Kathy Baisley; Kokugonza Mugeye; Clare Tanton; David Ross; Dean Everett; Tim Clayton; Rebecca Balira; Louise Knight; Ian Hambleton; Jerome Le Goff; Laurent Belec; Richard Hayes
Journal:  N Engl J Med       Date:  2008-03-12       Impact factor: 91.245

View more
  9 in total

Review 1.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

2.  BRIEF - SYNOPSIS OF THE CURRENT EVIDENCE ON THE RISK OF HIV TRANSMISSION.

Authors:  D Paquette; A Demers; M Gale-Rowe; T Wong
Journal:  Can Commun Dis Rep       Date:  2013-11-29

Review 3.  Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Reprod Immunol       Date:  2011-01-09       Impact factor: 3.886

4.  Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.

Authors:  Jared M Baeten; Erin Kahle; Jairam R Lingappa; Robert W Coombs; Sinead Delany-Moretlwe; Edith Nakku-Joloba; Nelly R Mugo; Anna Wald; Lawrence Corey; Deborah Donnell; Mary S Campbell; James I Mullins; Connie Celum
Journal:  Sci Transl Med       Date:  2011-04-06       Impact factor: 17.956

5.  Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?

Authors:  Megan Justine Huchko; Victoria Woo; Teri Liegler; Anna Leddy; Karen Smith-McCune; George F Sawaya; Elizabeth A Bukusi; Craig R Cohen
Journal:  J Low Genit Tract Dis       Date:  2013-07       Impact factor: 1.925

6.  Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.

Authors:  M J Huchko; V G Woo; T Liegler; H Leslie; K Smith-McCune; G F Sawaya; E A Bukusi; C R Cohen
Journal:  BJOG       Date:  2013-05-07       Impact factor: 6.531

7.  Effect of trichomoniasis therapy on genital HIV viral burden among African women.

Authors:  Brenna L Anderson; Cynthia Firnhaber; Tao Liu; Avril Swarts; Maureen Siminya; Jessica Ingersoll; Angela M Caliendo; Susan Cu-Uvin
Journal:  Sex Transm Dis       Date:  2012-08       Impact factor: 2.830

8.  Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.

Authors:  Rosa F Yeh; Naser L Rezk; Angela D M Kashuba; Julie B Dumond; Hiba L Tappouni; Hsiao-Chuan Tien; Ya-Chi Chen; Manoli Vourvahis; Amanda L Horton; Susan A Fiscus; Kristine B Patterson
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

Review 9.  The effect of sexually transmitted co-infections on HIV viral load amongst individuals on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  David Champredon; Steven E Bellan; Wim Delva; Spencer Hunt; Chyun-Fung Shi; Marek Smieja; Jonathan Dushoff
Journal:  BMC Infect Dis       Date:  2015-06-30       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.